On the alert for cytokine storm: Immunopathology in COVID-19

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey

Arthritis Care Res (Hoboken).

Sirotich E, Dillingham S, Grainger R, Hausmann JS, COVID-19 Global Rheumatology Alliance Steering Committee.

doi: 10.1002/acr.24257.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Ann Rheum Dis.

Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, Mateus EF, Rush S, Schmajuk G, Simard J, Strangfeld A, Trupin L, Wysham KD, Bhana S, Costello W, Grainger R, Hausmann JS, Liew JW, Sirotich E, Sufka P, Wallace ZS, Yazdany J, Machado PM, Robinson PC, COVID-19 Global Rheumatology Alliance.

doi: 10.1136/annrheumdis-2020-217871.

Psoriasis

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 2 - Advances in Psoriatic Disease Management, COVID-19 Vaccines, and COVID-19 Treatments

J Am Acad Dermatol

Gelfand JM, Armstrong AW, Bell S, Anesi GL, Blauvelt A, Calabrese C, Dommasch ED, Feldman SR, Gladman D, Kircik L, Lebwohl M, Lo Re V 3rd, Martin G, Merola JF, Scher JU, Schwartzman S, Treat JR, Van Voorhees AS, Ellebrecht CT, Fenner J, Ocon A, Syed MN, Weinstein EJ, Gondo G, Heydon S, Koons S, Ritchlin CT

doi: 10.1016/j.jaad.2020.12.058

Further Publications Dermatology

Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA

Lancet Psychiatry

Taquet M, Luciano S, Geddes JR, Harrison PJ

doi: 10.1016/S2215-0366(20)30462-4

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

Elevated plasma sTIM-3 levels in severe Covid-19 patients

J Allergy Clin Immunol.

Ueland T, Heggelund L, Lind A, Holten AR, Tonby K, Michelsen AE, Jenum S, Jørgensen MJ, Barratt-Due A, Skeie LG, Nordøy I, Aanensen Fraz MS, Quist-Paulsen E E, Pischke SE, Johal SK, Hesstvedt L, Bogen M, Fevang B, Halvorsen B, Müller F, Bekken GK, Mollnes TE, Dudman S, Aukrust P, Dyrhol-Riise AM, Holter JC

doi: 10.1016/j.jaci.2020.09.007.

Further Publications Rheumatology

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

RMD Open

Sattui SE, Liew JW, Kennedy K, Sirotich E, Putman M, Moni TT, Akpabio A, Alpízar-Rodríguez D, Berenbaum F, Bulina I, Conway R, Singh AD, Duff E, Durrant KL, Gheita TA, Hill CL, Howard RA, Hoyer BF, Hsieh E, El Kibbi L, Kilian A, Kim AH, Liew DFL, Lo C, Miller B, Mingolla S, Nudel M, Palmerlee CA, Singh JA, Singh N, Ugarte-Gil MF, Wallace J, Young KJ, Bhana S, Costello W, Grainger R, Machado PM, Robinson PC, Sufka P, Wallace ZS, Yazdany J, Harrison C, Larché M, Levine M, Foster G, Thabane L, Rider LG, Hausmann JS, Simard JF, Sparks JA

doi: 10.1136/rmdopen-2021-001814

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions

J Eur Acad Dermatol Venereol.

Balato A, Ayala F, Bruze M, Crepy MN, Gonçalo M, Duus Johansen J, John SM, Pigatto P, Raimondo A, Rustemeyer T, Schuttelaar MA, Svedman C, Aerst O, Uter W, Wilkinson M, Gimenez-Arnau A

doi: 10.1111/jdv.16557.

Systemic Lupus Erythematosus

Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients

Clin Immunol.

Sawalha AH, Zhao M, Coit P, Lu Q

doi: 10.1016/j.clim.2020.108410.

Further Publications DermatologyFurther Publications ImmunologyFurther Publications Rheumatology

COVID-19 revisiting inflammatory pathways of arthritis

Nat Rev Rheumatol.

Schett G, Manger B, Simon D, Caporali R

doi: 10.1038/s41584-020-0451-z.

Related content

Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 2 - Advances in Psoriatic Disease Management, COVID-19 Vaccines, and COVID-19 Treatments

Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA

Elevated plasma sTIM-3 levels in severe Covid-19 patients

Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey

European Task Force on Contact Dermatitis statement on coronavirus 19 disease (COVID-19) outbreak and the risk of adverse cutaneous reactions

Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients

COVID-19 revisiting inflammatory pathways of arthritis